NCT01971034View on ClinicalTrials.gov

Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2012

Conditions
Pancreatic Adenocarcinoma Advanced or Metastatic
Interventions
DRUG

Paclitaxel

80 mg/m2, IV, Day 1, Day 8 and Day 15.

DRUG

Metformin

850mg, PO, every 8 hours, daily.

Trial Locations (1)

01246000

ICESP, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER

NCT01971034 - Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure. | Biotech Hunter | Biotech Hunter